Cargando…
Decreased tumorigenesis in mice with a Kras point mutation at C118
KRAS, NRAS, or HRAS genes are mutated to encode an active oncogenic protein in a quarter of human cancers. Redox-dependent reactions can also lead to Ras activation in a manner dependent upon the thiol residue of cysteine 118 (C118). Here, to investigate the effect of mutating this residue on tumori...
Autores principales: | Huang, Lu, Carney, John, Cardona, Diana M., Counter, Christopher M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234187/ https://www.ncbi.nlm.nih.gov/pubmed/25394415 http://dx.doi.org/10.1038/ncomms6410 |
Ejemplares similares
-
Reduced HRAS(G12V)-Driven Tumorigenesis of Cell Lines Expressing KRAS(C118S)
por: Huang, Lu, et al.
Publicado: (2015) -
Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesis
por: Le Roux, Özgün, et al.
Publicado: (2022) -
Capturing the primordial Kras mutation initiating urethane carcinogenesis
por: Li, Siqi, et al.
Publicado: (2020) -
Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice
por: Weyandt, Jamie D., et al.
Publicado: (2016) -
Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic Cancer
por: Weyandt, Jamie D., et al.
Publicado: (2015)